Cigna (CI) EBITDA (2017 - 2026)

Cigna has disclosed EBITDA across 10 years of filings, most recently posting $2.7 billion for Q2 2026.

• In Q2 2026, EBITDA rose 16.05% year-over-year to $2.7 billion; the TTM figure through Jun 2026 stood at $10.0 billion (up 10.31% YoY), while the FY2025 annual figure was $9.2 billion, down 2.3% from the prior year.
• EBITDA came in at $2.7 billion for Q2 2026 at Cigna, up from $2.4 billion in the prior quarter.
• In the past five years, EBITDA ranged from a high of $2.7 billion in Q2 2026 to a low of $1.7 billion in Q4 2022.
• Average EBITDA over 5 years is $2.3 billion, with a median of $2.2 billion recorded in 2023.
• Year-over-year, EBITDA decreased 12.63% in 2025 and gained 19.63% in 2026.
• Over 5 years, EBITDA stood at $1.7 billion in 2022, then rose by 17.78% to $2.1 billion in 2023, then rose by 5.49% to $2.2 billion in 2024, then climbed by 7.92% to $2.3 billion in 2025, then rose by 14.12% to $2.7 billion in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $2.7 billion in Q2 2026, $2.4 billion in Q1 2026, and $2.3 billion in Q4 2025.